April 10, 2018
Categories: Dangerous Drugs
Parkinson’s Disease Treatment Drug Reports Deaths Spark
A new medication called Nuplazid, made by San Diego-based Acadia Pharmaceuticals had been designated a “breakthrough therapy” – meaning that it demonstrated “substantial improvement” in patients with serious or life-threatening diseases compared to treatments already on the market. The physician who led the FDA’s medical review, Dr. Paul Andreason, warned that patients taking the drug...
more →